Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study

  • Jasmina-Ziva Cerne1,
  • Vida Stegel2,
  • Ksenija Gersak1 and
  • Srdjan Novakovic2Email author
BMC Cancer201212:105

DOI: 10.1186/1471-2407-12-105

Received: 7 November 2011

Accepted: 22 March 2012

Published: 22 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
7 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Jan 2012 Reviewed Reviewer Report - Andreas Hadjisavvas
1 Feb 2012 Reviewed Reviewer Report - Julia Starmann
28 Feb 2012 Author responded Author comments - Srdjan Novakovic
Resubmission - Version 3
28 Feb 2012 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
5 Mar 2012 Reviewed Reviewer Report - Julia Starmann
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
22 Mar 2012 Editorially accepted
22 Mar 2012 Article published 10.1186/1471-2407-12-105

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Institute of Medical Genetics, Department of Obstetrics and Gynecology, University Medical Center Ljubljana
(2)
Department of Molecular Diagnostics, Institute of Oncology Ljubljana

Advertisement